Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

Bind Research launched to transform disordered proteins into effective drug targetsUK’s first not-for-profit Focused Research Organisation ...

The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

The Swiss biopharma company said the deal with the German National Association of Statutory Health Insurance Funds (GKV-SV) ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand ...

Fintel reports that on February 4, 2025, Baird initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with a Outperform recommendation. Analyst Price Forecast Suggests 47.68% Upside As of ...

Linkedin co-founder Reid Hoffman has launched a startup with the intention of using AI to fuel drug discovery. He is ...

Non-profit science and technology hub Catalyst has appointed one of Northern Ireland’s best-known science and technology leaders as its new director of innovation partnerships.

Discover the best sectors for growth stocks in the next decade. Explore which sectors may present an opportunity to bolster ...

Dear style & substance, I heard some disturbing news the other day, when an acquaintance was just needing someone to talk to. If what they told me is true, it could have some far-reaching devastating ...